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Abstract
The functional properties of a-amino-3-hydroxy-5-methy-4-isoxazole propionate (AMPA) receptors in different brain
regions, such as hippocampus and cerebellum, have been well studied in vitro and in vivo. The AMPA receptors
present a unique characteristic in the mechanisms of subunit regulation during LTP (long-term potentiation) and
LTD (long-term depression), which are involved in the trafficking, altered composition and phosphorylation of
AMPA receptor subunits. Accumulated data have demonstrated that spinal AMPA receptors play a critical role in
the mechanism of both acute and persistent pain. However, less is known about the biochemical regulation of
AMPA receptor subunits in the spinal cord in response to painful stimuli. Recent studies have shown that some
important regulatory processes, such as the trafficking of AMPA receptor subunit, subunit compositional changes,
phosphorylation of AMPA receptor subunits, and their interaction with partner proteins may contribute to spinal
nociceptive transmission. Of all these regulation processes, the phosphorylation of AMPA receptor subunits is the
most important since it may trigger or affect other cellular processes. Therefore, these study results may suggest an
effective strategy in developing novel analgesics targeting AMPA receptor subunit regulation that may be useful in
treating persistent and chronic pain without unacceptable side effects in the clinics.
Introduction
Glutamate synapses are involved in most excitatory neu-
rotransmission in the central nervous system (CNS).
The major glutamate receptor subtypes at glutamatergic
synapses are currently subdivided into ionotropic gluta-
mate receptors (ion channel forming) and metabotropic
glutamate receptors (G-protein coupled). The former
may include N-methyl-D-aspartate (NMDA) receptors
and non-NMDA receptors, such as AMPA and kainite
receptors. Cumulative evidence suggests that activity-
dependent changes in the efficacy of glutamatergic
synapses in pain transmission pathways greatly contri-
bute to chronic pain caused by tissue damage or nerve
injuries [1,2]. A great number of studies have addressed
the role of NMDA receptors and metabotropic gluta-
mate receptors in synapses between primary afferent
fibers and spinal neurons. It has been demonstrated that
the activation of NMDA receptors and metabotropic
glutamate receptors critically contributed to the
development of chronic nociceptive hypersensitivity fol-
lowing peripheral tissue damage or nerve injuries [1]. In
contrast, the AMPA glutamate receptors are originally
thought to mediate rapid excitatory neurotransmission
in the CNS. Recently, more studies had supported the
critical contributions of spinal AMPA receptors in the
development of both acute and chronic painful
responses [3-6].
AMPA receptors are widely distributed in the CNS.
The functional properties and regulations of AMPA
receptors in different brain regions, such as in the hip-
pocampus (during long-term potentiation) and the cere-
bellum (during long-term depression), have been well
studied both in vitro and in vivo. These studies suggest
that the glutamate-mediated excitatory synaptic trans-
mission efficiency is dependent on the number and
function of AMPA receptors at glutamatergic synapses.
The former is associated with the trafficking of AMPA
receptors and the latter, is influenced by AMPA recep-
tor subunit composition, post-transcriptional and post-
translational modifications, and their interacting pro-
teins [7-9]. Interestingly, several studies have shown that
the trafficking of AMPA receptors, their subunits com-
position, phosphorylation regulation of AMPA receptor
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role in the nociceptive processing of the spinal cord.
This review will bring together recent advances in
understanding the molecular mechanisms of spinal
AMPA receptor regulation and their implications in
nociception.
Structure of AMPA receptor channels, their
expression and localization in the spinal cord
As one of three classes of ionotropic glutamate recep-
tors, AMPA receptors were cloned and expressed in
recombinant systems in the late 1980s. Four homolo-
gous subunits, GluR1 to GluR4, assemble in various
combinations to form distinct AMPA receptors. Each
subunit includes an N-terminal extracellular amino
domain, a ligand-binding domain, a receptor-channel
domain, and an intracellular C-terminal domain [10,11].
Two polypeptide segments (S1 and S2) are localized in
the ligand-binding domain, which appear to represent
the agonist-recognition site. The receptor channel
domain consists of three transmembrane domains (M1,
M3, and M4) and one re-entrant loop within the mem-
brane (M2). The M2 loop participates in the formation
of the ion-channel pore. The C-terminal intracellular
regulation domain of theses subunits plays an especially
important role in the regulation of receptor function by
presenting multiple protein phosphorylation sites for
various known protein kinases, such as calcium/calmo-
dulin protein kinases II (CaMKII), protein kinase C
(PKC) and protein kinase A (PKA). AMPA receptors are
heteromeric molecules comprising various combinations
of GluR1, GluR2, GluR3, and GluR4 subunits. In the
CNS, GluR1 and GluR2 subunits are ubiquitously
expressed and are present in most AMPA receptors in
the adult mammalian CNS. In contrast to the GluR1,
GluR3 and GluR4 subunits, GluR2 contains an arginine
at a critical position in the pore-forming M2 segment.
Incorporation of GluR2 into heteromeric AMPA recep-
tor strongly reduces the permeability of influxed Ca
2+
ions and modifies current rectification and macroscopic-
channel conductance [12].
Immunohistochemical and in situ hybridization stu-
dies indicate that GluR1-4 subunits are all expressed in
the spinal dorsal horn [13]. There is a strong expression
of GluR1 in superficial dorsal horn such as in laminae I
-II, and a weaker expression in deeper dorsal horn lami-
nae. The expression of GluR2 was observed throughout
the dorsal horn and was abundant in inner lamina II
and sparse in outer lamina II. The deep laminae, III-IV,
show scattered cells staining for GluR1, GluR2/3, and
GluR4 [14,15]. Todd’s group showed that synaptic
AMPA receptors on the dendrites of the lamina III, IV
and the NK1 receptor projection neurons contained
GluR2, GluR3 and GluR4, but not GluR1 subunits [16].
Since GluR2 is widely expressed in the CNS, a majority
of AMPA receptors in the CNS present low permeability
for Ca
2+ influx. However, a high density of Ca
2+-perme-
able AMPA receptors is observed in the post-natal
spinal dorsal horn, particularly in the superficial spinal
laminae I and II, which may be involved in nociception
[17]. Activation of Ca
2+-permeable AMPA receptors in
the spinal dorsal horn can enhance the AMPA receptor-
mediated synaptic transmission [17].
Regulation of the spinal AMPA receptors in post-
synaptic membrane through the receptor
trafficking evoked by painful stimuli
The trafficking of AMPA receptors has been well stu-
died in glutamatergic neurons of hippocampus. These
studies have shown that AMPA receptors present some
distinctive characteristics in receptor trafficking from
cytosol to postsynaptic membrane (Figure 1). On one
hand, AMPA receptors may rapidly and constitutively
cycle between intracellular stores and the cellular mem-
brane surface [18,19]. On the other hand, AMPA recep-
tors in plasma membrane may exchange between the
extra-synaptic and synaptic membrane in a manner of
lateral diffusion [20]. The receptor-cycling event and lat-
eral diffusion can influence the number of AMPA recep-
tors in synapses and further changes the synapse
strength. It has been demonstrated that the regulation
of AMPA receptor cycling and surface trafficking plays
a critical role in the induction of LTP in hippocampal
neurons [21]. In contrast to the wealth of information
on the regulation of the AMPA receptor trafficking in
hippocampal neurons, much less is known about its
trafficking events in spinal nociceptive neurons following
painful stimuli. Many previous studies suggest that
spinal cord central sensitization resembles LTP in the
hippocampus [22,23]. Part of the mechanisms underly-
ing the LTP in the hippocampus may also apply to the
spinal cord. The current evidence supports the involve-
ment of AMPA receptor trafficking in spinal nocicep-
tion. In a mice model of visceral hyperalgesia, Galan et
al. demonstrated that a significant trafficking event of
GluR1 subunit of AMPA receptors from cytosol to
plasma membrane in spinal neurons existed and was
evoked by painful visceral stimuli [24]. Peripheral injury
may alter spinal AMPA receptor composition through
the transcriptional regulation of subunit gene expression
in an inflammatory pain model [25]. Nagy et al. showed
that some GluR1 subunits in the dorsal horn were phos-
phorylated at Serine
845 site following noxious stimula-
tion [15]. Since phosphorylation at this site is necessary
for the insertion of GluR1-containing receptors, this
provides the further evidence that noxious stimulation
m a yi n d u c ei n s e r t i o no fG l u R 1-containing receptors in
spinal neurons. The signaling pathways that drive the
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during LTP in vitro also require the activity of neuronal
CaMKII [26]. In spinal neurons, intra-thecal application
of a CaMKII inhibitor, KN-93, before the painful visc-
eral stimulus, apparently inhibits the GluR1 accumula-
tion in the plasma membrane fraction [24]. This
suggests that the painful visceral stimulus promote
synaptic delivery of GluR1-containing receptors in a
CaMKII-dependent manner. Larsson et al. showed that
in a rat model of acute inflammatory pain, hyperalgesia
was associated with an elevated density of GluR1-con-
taining AMPA receptors as well as an increased ratio of
GluR1 to GluR2/3 subunits at synapses. It suggests a
significant membrane translocation of GluR1-containing
AMPA receptors to a spinal nociceptive synapse during
acute noxious stimulation [27]. In an animal model of
complete Freund’s adjuvant (CFA)-induced persistent
inflammatory pain, Park et al. found that CFA-induced
inflammation did not change the total expression or dis-
tribution of AMPA receptor subunits, GluR1 and GluR2
in spinal dorsal horn, but did alter their subcellular dis-
tribution. They demonstrated that the amount of GluR2
was markedly increased in the crude cytosolic fraction
and decreased in the crude membrane fraction from the
ipsilateral L4-5 dorsal horn at 24 hour post-CFA injec-
tion. Conversely, the level of GluR1 was significantly
reduced in the crude cytosolic fraction and increased in
the crude membrane fraction from the ipsilateral L4-5
dorsal horn at 24 hour post-CFA injection [5]. All the
data demonstrated that the regulation of the spinal
AMPA receptors in postsynaptic membranes through
the receptor trafficking may play a remarkable role in
the AMPA receptor-mediated nociception.
Functional regulation of spinal AMPA receptors
through phosphorylation of receptor subunits
A variety of extra-, intra-cellular signals following per-
ipheral noxious stimulation trigger cellular and molecu-
lar changes at transcriptional, translational, or post-
translational levels, and theses events may contribute to
the central sensitization. The phosphorylation of mem-
brane receptors is an important post-translational
mechanism underlying synaptic plasticity in nervous sys-
tems as well as in pain modulation. Strong noxious sti-
mulation in the periphery tissues may activate several
protein kinase cascades, such as CaMKII, PKA, PKC,
Figure 1 Pathways of AMPA receptor trafficking. AMPA receptors may cycle between intracellular stores and the cell surface rapidly and
constitutively. AMPA receptors in plasma membrane may exchange between the extra-synaptic and synaptic membrane in a manner of lateral
diffusion. The receptor-cycling event and lateral diffusion can regulate the number of AMPA receptors in synapses and further changes the
synapse strength. PSD, post-synaptic density.
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phorylation of glutamate receptors in spinal nociceptive
neurons [23,28-30]. The increased sensitivity of gluta-
mate receptors through the phosphorylation regulated
by multiple intra-cellular protein kinases may contribute
to the enhanced responsiveness of dorsal horn neurons
during central sensitization [31-33]. As an important
class of glutamate receptors, phosphorylation of AMPA
receptor subunits has been widely investigated in rela-
tion to processes of synaptic plasticity in different brain
regions. It has been demonstrated that phosphorylation
of AMPA receptor subunits may potentiate their
activity, influence their interaction with intracellular
partner proteins, and promote their expression at the
plasma membrane during synaptic plasticity [34-37]. All
these intracellular events triggered by phosphorylation
of AMPA receptor subunits may contribute to the
enhanced efficacy of glutamatergic synapses (Figure 2).
In spinal neurons, accumulating evidence supports the
important role of the regulation of AMPA receptors by
phosphorylation in spinal nociceptive process.
The intracellular C-terminal domains of AMPA recep-
tor subunits may allow subunit-specific regulation by
phosphorylation. There are several protein
Figure 2 The phosphorylation of AMPA receptor subunits and its interaction with partner proteins in spinal neurons. In spinal neurons,
it has shown that PKA mediates the phosphorylation of serine at the Serine
845 site, and PKC targets the Serine
831 site following noxious
stimulation. More specifically, CaMKII mediates the phosphorylation of GluR1 subunit of AMPA receptor at both Serine
831 and Serine
845 sites in
spinal neurons after strong noxious peripheral stimulation. GluR2 subunits of AMPA receptors may bind to GRIP and PICK1, which play an
important role in the GluR2 trafficking. GRIP anchors GluR2 subunits at synapses, whereas PICK1 brings PKC to synaptic GluR2. PKC
phosphorylates GluR2 Serine
880 to release GluR2 from GRIP and to promote GluR2 internalization. CFA-induced peripheral inflammation could
induce GluR2 internalization in dorsal horn neurons. Stargazin binds to GluR1, 2, and 4. Binding of the Stargazin C-terminal tail to PSD-95
mediates the synaptic targeting of surface AMPA receptors. SAP 97 binds to the GluR1 C-terminus, interacts with the actin-associated protein
4.1N and is implicated in GluR1 synaptic insertion. NSF protein plays a role in membrane fusion processes and also interacts with GluR2 and
GluR3 subunits of AMPA receptors. The following abbreviations are used: PKA, protein kinase A; PKC, protein kinase C; CaMKII, Ca
2+/calmodulin-
dependent protein kinase II; GRIP, glutamate receptor interacting protein; PICK1, protein interacting with C-Kinase; CFA, complete Freund
Adjuvant; TARP, transmembrane AMPA receptor regulatory proteins; PDZ, postsynaptic density zone; PSD, postsynaptic density; SAP 97, synapse-
associated protein 97; NSF, N-ethylmaleimide sensitive fusion.
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which are working targets of PKA, PKC, and CaMKII.
In vitro studies on hippocampal slices show that AMPA
receptors can be directly phosphorylated on at least 12
distinct phosphorylation sites. Site-directed mutagenesis
and phosphopeptide analysis has identified the two
major phosphorylation sites on GluR1: Serine
845,w h i c h
is phosporylated majorly by PKA, and Serine
831,w h i c h
is phosphorylated majorly by PKC [38]. The phosphory-
lation of Serine
845 in GluR1 by PKA regulates the open-
channel probability of AMPA receptors; whereas the
phosphorylation of Serine
831 by PKC changes channel
conductance [39]. CaMKII was also found to phosphor-
ylate Serine
831 in GluR1 and contributes to the single-
channel conductance of the receptor and may increase
AMPA receptor conductance during LTP [35,40]. In
spinal neurons, our group has shown that PKA mediates
the phosphorylation of serine at the Serine
845 site, and
PKC targets the Serine
831 site following noxious stimula-
tion [23,31,41]. Furthermore, we have demonstrated that
AMPA receptors showed enhanced responsiveness to
nociceptive stimulation through this phosphorylation
processing during central sensitization. More specifically,
CaMKII may impact the phosphorylation of GluR1 sub-
unit of AMPA receptor at both Serine
831 and Serine
845
sites in neurons in the spinal cord after strong noxious
peripheral stimulation [23]. Phosphorylation of GluR1 at
Serine
831 by CaMKII in central sensitization is consis-
tent with the results of studies of LTP in the hippocam-
pus. CaMKII inhibitor, KN-93, partially blocked the
phosphorylation of GluR1 at the Serine
845 site, which is
a PKA phosphorylation site either. CaMKII may indir-
ectly mediate the phosphorylation of GluR1 at the Ser-
ine
845 site through adenylate cyclase and PKA, since the
Ca
2+-calmodulin complex can stimulate adenylate
cyclase, and subsequently activate more cAMP produc-
tion and PKA activity. Lu et al. demonstrated that phos-
phorylated GluR1 (phosphorylated GluR1-Serine
845 and
phosphorylated GluR1-Serine
831)m i g h tp l a yar o l ei n
the induction of inflammatory pain but not neuropathic
pain [42].
The phosphorylation of GluR2 plays an important role
in the receptor clusters during synaptic plasticity and
persistent pain. It has been demonstrated that GluR2
m a yb ep h o s p h o r y l a t e do nS e r i n e
880 by PKC in in vitro
and in transfected cells [36]. AMPA receptor GluR2
subunit may bind to cellular partner proteins, such as
glutamate receptor interacting protein (GRIP) and this
signal protein interacting with C-Kinase (PICK1), which
plays an important role in the synaptic GluR2 trafficking
[43,44]. As the PDZ domain-containing proteins, GRIP
anchors GluR2 at synapses while PICK1 brings PKC to
synaptic GluR2. PKC phosphorylates GluR2 at Serine
880
to release GluR2 from GRIP and to promote the
internalization of GluR2 [36]. The interference of the
interaction between GluR2 and GRIP by GluR2 phos-
phorylation apparently disrupts AMPA receptor GluR2
clusters [45]. It has been demonstrated that complete
Freund’s adjuvant (CFA)-induced peripheral inflamma-
tion may induce synaptic GluR2 internalization in spinal
dorsal horn neurons and this internalization was
initiated by PKC-mediated GluR2 phosphorylation at
Serine
880. Subsequently, the disruption of GluR2 binding
to its synaptic anchoring protein (GRIP) can result in a
switch of GluR2-containing AMPA receptors to GluR2-
lacking AMPA receptors. This disassociation may also
increase AMPA receptor Ca
2+ permeability at the
synapses in dorsal horn neurons [46]. Moreover, pre-
venting CFA-induced spinal GluR2 internalization
through targeted mutation of the GluR2 PKC phosphor-
ylation site could reduce CFA-evoked hypersensitivity
during the maintenance of nociceptive process. It may
suggest a potential strategy in developing selective
blockers targeting receptor single subunit or specific
post-translational points.
The phosphorylation of another subunit, GluR4 has
also been demonstrated to play an important role in
spinal nociception. GluR4 is the most rapidly desensitiz-
ing subunit of AMPA receptors and is phosphorylated
at Serine
842, within its C-terminal domain [47]. PKA,
PKC, and CaMKII may phosphorylate at Serine
842 site
of GluR4 very well. Threonine
830 is also found as an
important phosphorylation site on GluR4 by PKC [47].
Recently, Polgar et al. reported that postsynaptic GluR4-
containing AMPA receptors were involved in spinal
nociceptive transmission [48]. However, how GluR4
phosphorylation contributes to spinal nociception needs
further investigation.
Regulation of the interactions between AMPA
receptor subunits and associated partner proteins
in spinal cord neurons during nociception
In the past decades, it has been demonstrated that a
number of proteins interact with the intracellular C-ter-
mini of postsynaptic AMPA receptor GluR1-4 subunits.
These proteins are closely associated with the trafficking
of AMPA receptor subunits and the subsequent regula-
tion of intracellular signal transduction cascades. It has
been demonstrated from previous studies that the regu-
lated synaptic insertion of AMPA receptor subunits
through the interactions of subunits with protein part-
ners can play a critical role in spinal dorsal horn sensiti-
zation [46,49] (Figure 2).
Other critical PDZ-domain-containing proteins, such
as GRIP and ABP were found to interact with the xS/
TxV motif at the extreme C-terminal of short forms of
AMPA receptor subunits [43,50]. The interaction of
GluR2 and GRIP plays a significant role in clustering
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model of neuropathic pain [13]. It has been found that
phosphorylation of GluR2 at Serine
880 by PKC reduces
the affinity of GluR2 for GRIP, thus, released GluR2
from GRIP and promotes the internalization of GluR2
[36]. Recently, the internalization of spinal GluR2 subu-
nit of AMPA receptor has also been demonstrated in an
animal model of persistent inflammatory pain [46]. The
internalization of phosphorylated GluR2 subunit of
AMPA receptors may result in an increased synaptic
ratio of GluR1 to GluR2 subunit since the membrane
translocation of phosporylated GluR1 subunit to a spinal
nociceptive synapse may occur during noxious stimula-
tion [24,27]. The increased synaptic ratio of GluR1 to
GluR2 subunit, in turn, might result in an increase in
spinal Ca
2+-permeable AMPA receptors in the spinal
dorsal horn. A study in GluR2-deficient mice has shown
that an increase in spinal Ca
2+-permeable AMPA recep-
tors might facilitate nociceptive plasticity and enhance
long-lasting inflammatory hyperalgesia [51]. Taken
together, the interaction between GluR2 and GRIP in
spinal neurons might be involved in the nociceptive reg-
ulation through affecting the internalization of GluR2.
PICK1 has also been found to bind to the C-terminal
of GluR2, -3, -4 subunits of AMPA receptors through
the PDZ domain [44]. PICK1 was observed to partici-
pate in regulating synaptic AMPA receptor at various
levels [52]. On one hand, PICK1 can dimerise and the
dimers may induce the aggregation of AMPA receptors
in heterologous expression systems [44]. On the other
hand, PICK1 dimers could bring PKCa to AMPA recep-
tors and present a selective phosphorylation site of
GluR2 at Serine
880 [53-55]. This phosphorylation of
GluR2 on Serine
880 may further impede the affinity of
GluR2 for GRIP, release GluR2 from GRIP-GluR2 com-
plex and finally lead to the internalization of GluR2
subunits.
As a family member of trans-membrane AMPA recep-
tor regulatory proteins (TARP), Stargazin binds to
GluR1, -2, and -4 at sites other than PDZ target motifs.
Stargazin plays a critical role in the regulation of AMPA
receptor trafficking between synaptic and extra-synaptic
sites. Binding of the C-terminal tail of Stargazin to PDZ
domains of a number of synaptic scaffolding proteins,
such as PSD-95 (an interacting protein associated with
NR2 subunits of the NMDA receptors) may mediate the
synaptic targeting of surface AMPA receptors [56].
PSD-95 has been shown to play a crucial role in spinal
mechanisms of central sensitization following noxious
stimuli [57-59]. Thus, it may suggest that the Stargazin-
mediated interaction of AMPA receptors with PSD-95 is
possibly implicated in the spinal sensitization. The
translocation of AMPA receptors from the cytosol to
t h ep l a s m am e m b r a n ea l s or e q u i r e st h ei n v o l v e m e n to f
Stargazin. It has been showed that an over-expression of
Stargazin increases the number of extra-synaptic AMPA
receptors without affecting AMPA receptor-mediated
synaptic transmission. But, the over-expression of PSD-
95 may enhance AMPA receptor-mediated synaptic
responses. Studies may suggest a critical role of Starga-
zin in the regulation of AMPA receptor trafficking from
extra-synaptic to synaptic sites, thus it leads to the con-
trollable events of AMPA receptor-PSD-95 complex
[56].
The GluR1 subunit of AMPA receptors may also
have the interaction with some regulatory proteins
through its termini. In hippocampal neurons, the inter-
action of GluR1 with its partner proteins has been
thought to be involved in controlling receptor traffick-
ing and synaptic insertion during neuronal plasticity
[52,60,61]. It has been studied that the CaMKII-depen-
dent trafficking of GluR1 subunit to dendritic spines
required the PDZ target motif in GluR1 subunit [62].
Another PDZ domain protein, synapse-associated pro-
tein 97 (SAP 97) binds to the C-terminus of GluR1
subunit and interacts with the actin-associated protein
4.1N (which can also bind GluR1 subunit). Their inter-
action was reported to be involved in the synaptic
insertion of GluR1 subunit [63]. Since more evidences
support that the role of phosphorylation of GluR1 sub-
unit of AMPA receptors in acute and chronic inflam-
matory pain [42], it may propose a novel mechanism
that the interaction of GluR1 subunit of AMPA recep-
tors with its partner proteins was implicated during
spinal hyper-sensitivity.
The role of Non-PDZ domain-containing protein,
such as N-ethylmaleimide sensitive fusion (NSF) protein
(an ATPase), in neuronal membrane fusion processes
and regulatory interaction with GluR2 and GluR3 subu-
nits of AMPA receptors has been investigated. The
interaction may be responsible for the insertion and sta-
bilization of AMPA receptors containing GluR2/3 subu-
nits [64]. Garry et al. reported that cell-permeable
blocking peptides targeting for interactions of GluR2
with NSF or for GluR2/3-GRIP/PICK1 complex may
have anti-hyperalgesic effects in a neuropathic pain
model [13]. Recently, Katano’s group had also shown
that NSF is involved in central sensitization in the spinal
cord through a switch of GluR2 subunit composition in
a CFA-induced peripheral inflammatory pain model
[65].
In summary, the interaction of AMPA receptor subu-
nits with their partner proteins was extensively involved
in the processes of the regulation of post-translational
modification, such as trafficking, internalization and sur-
face expression. All these events may influence the
AMPA receptor-mediated synaptic transmission as well
as spinal central sensitization.
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through the composition switch of its subunits
Incorporation of GluR2 subunits into heteromeric
AMPA receptor strongly reduces the permeability of the
AMPA receptor channel to Ca
2+ ion influx [66]. Thus,
the switch in the composition of synaptic AMPA recep-
tors may greatly influence the AMPA receptor-mediated
synaptic efficacy. The rapid alterations in the composi-
tion of synaptic AMPA receptors induced by various sti-
muli may occur in the cerebellum, the hippocampus
and the cortex. Current evidence also shows that a per-
sistent activation of primary nociceptive afferent fibers
may rapidly regulate synaptic AMPA receptor composi-
tion in the spinal neurons. For example, noxious stimuli
can change the expression ratio of synaptic AMPA
receptor subunits GluR1 to GluR2 in a visceral pain
model [24]. Peripheral injury may also alter the spinal
AMPA receptor composition in inflammatory pain pro-
cess [65]. Hartmann et al. reported that the GluR1 and
GluR2 subunits reciprocally modulate spinal synaptic
plasticity and inflammatory pain in GluR1-knockout
mice [51]. A reduction in the number of Ca
2+-perme-
able AMPA receptors and density of AMPA-channel
currents in spinal neurons in GluR1-deficient mice is
accompanied by a loss of nociceptive plasticity and a
reduction in acute inflammatory hyperalgesia [51]. In
contrast, an increase in spinal Ca
2+-permeable AMPA
receptors in GluR2-deficient mice facilitated nociceptive
plasticity and enhanced long-lasting inflammatory
hyperalgesia [51]. It supports that peripheral inflamma-
tion might induce the switch of Ca
2+-permeable AMPA
receptors in dorsal horn neurons [46,65,67].
The rapid alterations in the composition of synaptic
AMPA receptors induced by physiologic activity or nox-
ious stimuli can be achieved by modulating the phos-
phorylation status of GluR1 and GluR2 subunits and
their binding to PDZ domain-containing synaptic scaf-
folding proteins. Thus it may change the membrane tar-
geting and synaptic availability of AMPA receptors.
CFA-induced peripheral inflammation could induce
synaptic GluR2 internalizati o ni ns p i n a ld o r s a lh o r n
neurons during nociception processing and this interna-
lization might be initiated by the phosphorylation of
GluR2 at Serine
880 by PKC. It subsequently disrupted
the binding of GluR2 subunits to synaptic anchoring
protein (GRIP) and result in a switch of GluR2-contain-
ing AMPA receptors to GluR2-lacking AMPA receptors.
Finally, an increased AMPA receptor Ca
2+ permeability
induced more Ca
2+ influx in dorsal horn neurons [46].
NSF is also reported to be involved in central sensitiza-
tion in the spinal cord through a composition switch of
GluR2 subunit following CFA-induced peripheral
inflammation [65]. Additionally, potential changes in
GluR2 mRNA editing in disease states may modulate
nociceptive responses by altering AMPA receptor com-
position in the spinal dorsal horn. Dysfunctional GluR2
editing has been reported in the human spinal cord in
several neurodegenerative diseases, such as amyotrophic
lateral sclerosis. It deserves to be investigated to observe
whether similar changes occur in patients suffering from
chronic inflammatory or neuropathic pain [68].
Concluding remark
AMPA receptor subunits may present unique character-
istics in the receptor trafficking, subunit phosphoryla-
tion, interaction with partner proteins, and composition
changes in response to noxious stimuli. All of these
molecular events are closely associated with the develop-
ment or maintenance of persistent pain. The phosphory-
lation of AMPA receptor subunit may be the most
important process because it can trigger or affect other
associated processes. For example, the phosphorylation
of GluR1 subunit through CaMKII drives synaptic deliv-
ery of GluR1-containing receptors following painful sti-
muli. The phosphorylation of GluR2 subunit at Serine
880
by PKC may lead to disrupt the interaction between
GluR2 and GRIP and follow by GluR2 internalization.
The phosphorylation status of GluR1 and GluR2 subu-
nits modulates the rapid alterations in the composition
of synaptic AMPA receptors. The development of selec-
tive drugs based on targeting receptor single subunit- or
specific post-translational site may provide an effective
novel strategy in treating persistent or chronic pain.
Acknowledgements
This work was funded by Sealy Grant 2951-02, NIH P30/DK 56338-02/05, DE
15814, NS11255, 40723 and National Natural Science Foundation of China,
30801073/C160202 to Yun Wang.
Author details
1Department of Anesthesiology, Beijing Chaoyang Hospital, Capital Medical
University, Beijing 100020, PR China.
2Department of Anesthesiology and
Critical Care Medicine, Johns Hopkins University School of Medicine,
Baltimore, MD 21205, USA.
3Department of Neuro-Oncology, The University
of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
4Division of
Neurosurgery, Department of Surgery, The University of Texas Medical
Branch, Galveston, TX 77555-0517, USA.
5Department of Neuroscience and
Cell Biology, The University of Texas Medical Branch, Galveston, TX 77555-
0517, USA.
Authors’ contributions
YW participated in the design of the review and drafted the manuscript. JW,
ZW and QL assisted with the preparation of the manuscript and figures. YY
and LF conceived of the review and participated in its design and helped to
draft the manuscript. All authors read and approved the final manuscript.
All authors have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 25 September 2009
Accepted: 21 January 2010 Published: 21 January 2010
Wang et al. Molecular Pain 2010, 6:5
http://www.molecularpain.com/content/6/1/5
Page 7 of 9References
1. Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain.
Science 2000, 288:1765-1769.
2. Sandkuhler J: Learning and memory in pain pathways. Pain 2000,
88:113-118.
3. Jin HC, Keller AJ, Jung JK, Subieta A, Brennan TJ: Epidural tezampanel, an
AMPA/kainite receptor antagonist, produces postoperative analgesia in
rats. Anesth Analg 2007, 105:1152-1159.
4. Lee HJ, Pogatzki-Zahn EM, Brennan TJ: The effect of the AMPA/kainite
receptor antagonist LY293558 in a rat model of postoperative pain. J
Pain 2006, 7:768-777.
5. Park JS, Yaster M, Guan X, Xu JT, Shih MH, Guan Y, Raja SN, Tao YX: Role of
spinal cord alpha-amino-3-hydroxy-5-methy-4-isoxazolepropionic acid
receptors in complete Freund’s adjuvant-induced inflammatory pain.
Mol Pain 2008, 4:67.
6. Gormsen L, Finnerup NB, Almgvist PM, Jensen TS: The efficacy of the
AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a
randomized, double-blind, placebo-controlled, three-way crossover
study. Anesth Analg 2009, 108:1311-1319.
7. Bredt DS, Nicoll RA: AMPA receptor trafficking at excitatory synapses.
Neuron 2003, 40:361-379.
8. Gardner SM, Takamiya K, Xia J, Suh JG, Johnson R, Yu S, Huganir RL:
Calcium-permeable AMPA receptor plasticity is mediated by subunit-
specific interactions with PICK1 and NSF. Neuron 2005, 45:903-915.
9. Lee HK, Takamiya K, Han JS, Man H, Kim CH, Rumbaugh G, Yu S, Ding L,
He C, Petralia RS, Wenthold RJ, Gallagher M, Huganir RL: Phosphorylation
of the AMPA receptor GluR1 subunit is required for synaptic plasticity
and retention of spatial memory. Cell 2003, 112:631-643.
10. Soderling TR, Derkach VA: Postsynaptic protein phosphorylation and LTP.
Trends Neurosci 2000, 23:75-80.
11. Song I, Huganir RL: Regulation of AMPA receptors during synaptic
plasticity. Trends Neurosci 2002, 25:578-588.
12. Bleakman D, Lodge D: Neuropharmacology of AMPA and kainate
receptors. Neuropharmacology 1998, 37:1187-1204.
13. Garry EM, Moss A, Rosie R, Delaney A, Mitchell R, Fleetwood-Walker SM:
Specific involvement in neuropathic pain of AMPA receptors and
adapter proteins for the GluR2 subunit. Mol Cell Neurosci 2003, 24:10-22.
14. Polgar E, Watanabe M, Hartmann B, Grant SG, Todd AJ: Expression of
AMPA receptor subunits at synapses in laminae I-III of the rodent spinal
dorsal horn. Mol Pain 2008, 4:5.
15. Nagy GG, Al-Ayyan M, Andrew D, Fukaya M, Watanabe M, Todd AJ:
Widespread expression of the AMPA receptor GluR2 subunit at
glutamatergic synapses in the rat spinal cord and phosphorylation of
GluR1 in response to noxious stimulation revealed with an antigen-
unmasking method. J neurosci 2004, 24:5766-5777.
16. Todd AJ, Polgar E, Watt C, Bailey ME, Watanabe M: Neurokinin 1 receptor-
expressing projection neurons in laminae III and IV of the rat spinal cord
have synaptic AMPA receptors that contain GluR2, GluR3 and GluR4
subunits. Eur J Neurosci 2009, 29:718-726.
17. Engelman HS, Allen TB, MacDermott AB: The distribution of neurons
expressing calcium-permeable AMPA receptors in the superficial
laminae of the spinal cord dorsal horn. J Neurosci 1999, 19:2081-2089.
18. Malinow R, Malenka RC: AMPA receptor trafficking and synaptic plasticity.
Annu Rev Neurosci 2002, 25:103-126.
19. Sheng M, Kim MJ: Postsynaptic signaling and plasticity mechanisms.
Science 2002, 298:776-780.
20. Choquet D, Triller A: The role of receptor diffusion in the organization of
the postsynaptic membrane. Nat Rev Neurosci 2003, 4:251-265.
21. Kakegawa W, Tsuzuki K, Yoshida Y, Kameyama K, Ozawa S: Input- and
subunit-specific AMPA receptor trafficking underlying long-term
potentiation at hippocampal CA3 synapses. Eur J Neurosci 2004,
20:101-110.
22. Ji RR, Kohno T, Moore KA, Woolf CJ: Central sensitization and LTP: do pain
and memory share similar mechanisms?. Trends Neurosci 2003, 26:696-705.
23. Fang L, Wu J, Lin Q, Willis WD: Calcium-calmodulin-dependent protein
kinase II contributes to spinal cord central sensitization. J Neurosci 2002,
22:4196-4204.
24. Galan A, Laird JM, Cervero F: In vivo recruitment by painful stimuli of
AMPA receptor subunits to the plasma membrane of spinal cord
neurons. Pain 2004, 112:315-323.
25. Katano T, Furue H, Okuda-Ashitaka E, Tagaya M, Watanabe M, Yoshimura M,
Ito S: N-ethylmaleimide-sensitive fusion protein (NSF) is involved in
central sensitization in the spinal cord through GluR2 subunit
composition switch after inflammation. Eur J Neurosci 2008, 27:3161-3170.
26. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR: Regulatory
phosphorylation of AMPA-type glutamate receptors by CaMK II during
long-term potentiation. Science 1997, 276:2042-2045.
27. Larsson M, Broman J: Translocation of GluR1-containing AMPA receptors
to a spinal nociceptive synapse during acute noxious stimulation. J
Neurosci 2008, 28:7084-7090.
28. Fu Y, Han J, Ishola T, Scerbo M, Adwanikar H, Ramsey C, Neugebauer V:
PKA and ERK, but not PKC, in the amygdala contribute to pain -related
synaptic plasticity and behavior. Mol Pain 2008, 4:26.
29. Kim HW, Roh DH, Yoon SY, Seo HS, Kwon YB, Han HJ, Kim KW, Beitz AJ,
Lee JH: Activation of the spinal sigma-1 receptor enhances NMDA-
induced pain via PKC- and PKA-dependent phosphorylation of the NR1
subunit in mice. Br J Pharmacol 2008, 154:1125-1134.
30. Kohno T, Wang H, Amaya F, Brenner GJ, Cheng JK, Ji RR, Woolf CJ:
Bradykinin enhances AMPA and NMDA receptor activity in spinal cord
dorsal horn neurons by activating multiple kinases to produce pain
hypersensitivity. J neurosci 2008, 28:4533-4540.
31. Fang L, Wu J, Lin Q, Willis WD: Protein kinases regulate the
phosphorylation of the GluR1 subunit of AMPA receptors of spinal cord
in rats following noxious stimulation. Molecular Brain Research 2003,
118:160-165.
32. Zou X, Lin Q, Willis WD: Enhanced phosphorylation of NMDA receptor 1
subunits in spinal cord dorsal horn and spinothalamic tract neurons
after intradermal injection of capsaicin in rats. J Neurosci 2000,
20:6989-6997.
33. Zou X, Lin Q, Willis WD: Role of Protein kinase A in phosphorylation of
NMDA receptor 1 subunits in dorsal horn and spinothalamic tract
neurons after intradermal injection of capsaicin in rats. Neuroscience
2002, 115:775-786.
34. Tan SE, Wenthold RJ, Soderling TR: Phosphorylation of AMPA-type
glutamate receptors by calcium/calmodulin-dependent protein kinase II
and protein kinase C in cultured hippocampal neurons. J Neurosci 1994,
14:1123-1129.
35. Derkach V, Barria A, Soderling TR: Ca
2+/camodulin-kinase II enhances
channel conductance of a-amino-3-hydroxy-5-methy-4-
isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci USA
1999, 96:3269-3274.
36. Matsuda S, Mikawa S, Hirai H: Phosphorylation of serine-880 in GluR2 by
protein kinase C prevents its C terminus from bingding with glutamate
receptor-interacting protein. J Neurochem 1999, 73:1765-1768.
37. Esterban JA, Shi SH, Wilson C, Nuriya M, Huganir RL, Malinow R: PKA
phosphorylation of AMPA receptor subunits controls synaptic trafficking
underlying plasticity. Nat Neurosci 2003, 6:136-143.
38. Roche KW, O’Brien RJ, Mammen AL, Bernhardt J, Huganir RL:
Characterization of multiple phosphrylation sites on the AMPA receptor
GluR1 subunit. Neuron 1996, 16:1179-1188.
39. Banke TG, Bowie D, Lee HK, Huganir RL, Schousboe A, Traynelis SF: Control
of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J
Neurosci 2000, 20:89-102.
40. Manmen AL, Kameyama K, Roche KW, Huganir RL: Phosphorylation of the
a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor GluR1
subunit by calcium/calmodulin-dependent kinase II. J Biol Chem 1997,
272:32528-32533.
41. Fang L, Wu J, Zhang X, Lin Q, Willis WD: Increased phosphorylation of the
GluR1 subunit of spinal cord alpha-amino-3-hydroxy-5 methyl-4-
isoxazole propionate receptor in rats following intradermal injection of
capsaicin. Neuroscience 2003, 122:237-245.
42. Lu Y, Sun YN, Wu X, Sun Q, Liu FY, Xing GG, Wan Y: Role of a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionate receptor subunits GluR1 in
spinal dorsal horn in inflammatory nociception and neuropathic
nociception in rat. Brain Research 2008, 1200:19-26.
43. Dong H, O’Brien RL, Fung ET, Lanahan AA, Worley PF, Huganir RL: GRIP: a
synaptic PDZ domain-containing protein that interacts with AMPA
receptors. Nature 1997, 386:279-284.
44. Xia J, Zhang X, Staudinger J, Huganir RL: Clustering of AMPA receptors by
the synaptic PDZ domain-containing protein PICK1. Neuron 1999,
22:179-187.
Wang et al. Molecular Pain 2010, 6:5
http://www.molecularpain.com/content/6/1/5
Page 8 of 945. Matsuda S, Launey T, Mikawa S, Hirai H: Disruption of AMPA receptor
GluR2 clusters following long-term depression induction in cerebellar
Purkinje neurons. EMBO J 2000, 19:2765-2774.
46. Park JS, Voitenko N, Petralia RS, Guan X, Xu JT, Steinberg JP, Takamiya K,
Sotnik A, Kopach O, Huganir RL, Tao YX: Persistent inflammation induces
GluR2 internalization via NMDA receptor-triggered PKC activation in
dorsal horn neurons. J Neurosci 2009, 29:3206-3219.
47. Carvalho AL, Kameyama K, Huganir RL: Characterization of
phosphorylation sites on the glutamate receptor 4 subunit of the AMPA
receptors. J Neurosci 1999, 19:4748-4754.
48. Polgar E, Al-Khater KM, Shehab S, Watamabe M, Todd AJ: Large projection
neurons in lamina I of the rat spinal cord that lack the neurokinin 1
receptor are densely innervated by VGLUT2-containing axons and
possess GluR4-containing AMPA receptors. J Neurosci 2008,
28:13150-13160.
49. Gu JG, Albuquerque C, Lee CJ, MacDermott AB: Synaptic strengthening
through activation of Ca2+-permeable AMPA receptors. Nature 1996,
381:793-796.
50. Srivastava S, Osten P, Vilim FS, Khatri L, Inman G, States B, Daly C,
DeSouza S, Abagyan R, Valtschanoff JG, Weinberg RJ, Ziff EB: Novel
anchorage of GluR2/3 to the postsynaptic density by AMPA receptor-
binding protein ABP. Neuron 1998, 21:581-591.
51. Hartmann B, Ahmadi S, Heppenstall PA, Lewin GR, Schott C, Borchardt T,
Seeburg PH, Zeilhofer HU, Sprengel R, Kuner R: The AMPA receptor
subunits GluR-A and GluR-B reciprocally modulate spinal synaptic
plasticity and inflammatory pain. Neuron 2004, 44:637-650.
52. Luscher C, Frerking M: Restless AMPA receptors: implications for synaptic
transmission and plasticity. Trends Neurosci 2001, 24:665-670.
53. Dev KK, Nakanishi S, Henley JM: The PDZ domain of PICK1 differentially
accepts protein kinase C-alpha and GluR2 as interacting ligands. J Biol
Chem 2004, 279:41393-41397.
54. Perez JL, Khatri L, Chang C, Srivastava S, Osten P, Ziff EB: PICK1 targets
activated protein kinase Calpha to AMPA receptor clusters in spines of
hippocampal neurons and reduces surface levels of the AMPA-type
glutamate receptor subunit 2. J Neurosci 2001, 21:5417-5428.
55. Ataudinger J, Lu J, Olson EN: Specific interaction of the PDZ domain
protein PICK1 with the COOH terminus of protein kinase C-alpha. J Biol
Chem 1997, 272:32019-32024.
56. Schnell E, Sizemore M, Karimzadegan S, Chen L, Bredt DS, Nicoll RA: Direct
interactions between PSD-95 and stargazing control synaptic AMPA
receptor number. Proc Natl Acad Sci USA 2002, 99:13902-13907.
57. Garry EM, Moss A, Delaney A, O’Neill F, Blakemore J, Bowen J, Husi H,
Mitchell R, Grant SG, Fleetwood-Walker SM: Neuropathic sensitization of
behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions
are disrupted in PSD-95 mutant mice. Curr Biol 2003, 13:321-328.
58. Tao F, Su Q, Johns RA: Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits
chronic inflammatory pain behaviors in mice. Mol Ther 2008,
16:1776-1782.
59. Tao F, Tao YX, Gonzalez JA, Fang M, Mao P, Johns RA: Knockdown of PSD-
95/SAP90 delays the development of neuropathic pain in rats.
Neuroreport 2001, 12:3251-3255.
60. Passafaro M, Piech V, Sheng M: Subunit-specific temporal and spatial
patterns of AMPA receptor exocytosis in hippocampal neurons. Nat
Neurosci 2001, 4:917-926.
61. Shi S, Hayashi Y, Esteban JA, Malinow R: Subunit-specific rules governing
AMPA receptor trafficking to synapses in hippocampal pyramidal
neurons. Cell 2001, 105:331-343.
62. Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, Malinow R: Driving
AMPA receptors into synapses by LTP and CaMKII: requirement for
GluR1 and PDZ domain interaction. Science 2000, 287:2262-2267.
63. Shen L, Liang F, Walensky LD, Huganir RL: Regulation of AMPA receptor
GluR1 subunit surface expression by a 4.1N-linked actin cytoskeletal
association. J Neurosci 2000, 20:7932-7940.
64. Nishimune A, Isaac JT, Molnar E, Noel J, Nash SR, Tagaya M, Collingridge GL,
Nakanishi S, Henley JM: NSF binding to GluR2 regulates synaptic
transmission. Neuron 1998, 21:87-97.
65. Katano T, Furue H, Okida-Ashitaka E, Tagaya M, Watanabe M, Yoshimura M,
Ito S: N-ethylmaleimide-sensitive fusion protein (NSF) is involved in
central sensitization in the spinal cord through GluR2 subunit
composition switch after inflammation. Eur J Neurosci 2008, 27:3161-3170.
66. Burnashev N, Monyer H, Seeburg PH, Sakmann B: Divalent ion
permeability of AMPA receptor channels is dominated by the edited
form of a single subunit. Neuron 8:189-198.
67. Vikman KS, Rvcroft BK, Christie MJ: Switch to Ca2+-permeable AMPA and
reduced NR2B NMDA receptor-mediated neurotransmission at dorsal
horn nociceptive synapses during inflammatory pain in the rat. J Physiol
2008, 586:515-527.
68. Kwak S, Kawahara Y: Deficient RNA editing of GluR2 and neuronal death
in amyotropic lateral sclerosis. J Mol Med 2005, 83:110-120.
doi:10.1186/1744-8069-6-5
Cite this article as: Wang et al.: Regulation of AMPA receptors in spinal
nociception. Molecular Pain 2010 6:5.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Wang et al. Molecular Pain 2010, 6:5
http://www.molecularpain.com/content/6/1/5
Page 9 of 9